BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kara A, Tahir M, Snyderman W, Brinkman A, Fadel W, Dbeibo L. Why do clinicians order inappropriate Clostridium difficile testing? An exploratory study. Am J Infect Control 2019;47:285-9. [PMID: 30392996 DOI: 10.1016/j.ajic.2018.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Karlovich NS, Sata SS, Griffith B, Coop A, Kalu IC, Engemann JJ, Seidelman J, Turner NA, Polage CR, Smith BA, Lewis SS. In pursuit of the holy grail: Improving C. difficile testing appropriateness with iterative electronic health record clinical decision support and targeted test restriction. Infect Control Hosp Epidemiol 2021;:1-8. [PMID: 34085622 DOI: 10.1017/ice.2021.228] [Reference Citation Analysis]
2 Dbeibo L, Brinkman A, Beeler C, Fadel W, Snyderman W, Hatfield N, Sadowski J, Wang Y, Kelley K, Webb D, Azar J, Kara A. Utilizing a real-time discussion approach to improve the appropriateness of Clostridioides difficile testing and the potential unintended consequences of this strategy. Infect Control Hosp Epidemiol 2020;41:1215-8. [PMID: 32594961 DOI: 10.1017/ice.2020.276] [Reference Citation Analysis]
3 Zaver HB, Moktan VP, Harper EP, Bali A, Nasir A, Foulks C, Kuhlman J, Green M, Algan GA, Parth HC, Wu-Ballis M, DiCicco S, Smith BT, Owen RN, Mai LS, Spiros SL, Griffis J, Ramsey Walker DT, Hata DJ, Oring JM, Powers HR, Bosch W. Reduction in Health Care Facility-Onset Clostridioides difficile Infection: A Quality Improvement Initiative. Mayo Clin Proc Innov Qual Outcomes 2021;5:1066-74. [PMID: 34820598 DOI: 10.1016/j.mayocpiqo.2021.09.004] [Reference Citation Analysis]